Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for serin protease inhibitor
Most Correlated Studies
- Burkitt lymphoma cell treated with serine protease inhibitor TPCK or NF-κB inhibitor Bay 11-7082
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- Drug target sets for approved compounds
Most Relevant Literature
- SerpinA3N Regulates the Secretory Phenotype of Mouse Senescent Astrocytes Contributing to Neurodegen…
- Serpina3n/serpina3 alleviates cyclophosphamide-induced interstitial cystitis by activating the Wnt/β…
- SerpinA3N deficiency attenuates steatosis and enhances insulin signaling in male mice.
- Neuronal Serpina3n is an endogenous protector against blood brain barrier damage following cerebral …
- Therapeutical Significance of Serpina3n Subsequent Cerebral Ischemia via Cytotoxic Granzyme B Inacti…
Most Relevant Clinical Trials
- Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease
- Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 …
- RhDNase and Biodistribution of PMN Serine Proteases in Cystic Fibrosis Sputum
- STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19
- Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMepra…
